An implanted ultrasound device with immune drugs for new glioblastoma
Original title: Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage trial, still testing safety and how well it works.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial tests a device that helps immune drugs reach a brain tumor.
Who this trial is for. This trial is for people with newly diagnosed glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. It tests a device, placed after radiation, that helps drugs reach the brain.
Where it stands. The trial is checking if this is safe and doable. It is also checking if it helps treat glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. The trial has not reported results yet.
What this means, and what it doesn't
What it could mean: If this pans out, it could be a new way to get immune drugs into the brain. Someone who fits might ask their care team about this trial.
What it doesn't mean: This does not mean the treatment works. A trial is a test, not proven care. Being in one is no promise of help. It is not a cure.
Source: ClinicalTrials.gov, August 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.